Dr. Lian-Shun Feng obtained his PhD degree from Tsinghua University in 2011, and then worked as postdoctoral researcher in Peking University. Currently, Dr. Lian-Shun Feng work in WuXi AppTec as principal investigator. In 2017 and 2018, around 20 peer-reviewed SCI papers were published and many of them were cited over 100 times in two years.
Athina Geronikaki Department Pharmaceutical Chemistry School of Pharmacy University of Thessaloniki Thessaloniki (Greece)
Dr. Athina Geronikaki graduated in the field of Organic Chemistry from Tashkent State University in 1971 and received her PhD in 1977. In 1984, she graduated from School of Pharmacy of Aristotelian University of Thessaloniki. From 2006-2016, she was the Head of the Department of Pharm. Chemistry. Since 2010, she has been a Full Professor of Medicinal Chemistry of School of Pharmacy of Aristotle University of Thessaloniki. During 2009-2011, she was Vice President of School of Pharmacy of Aristotle University of Thessaloniki. In July 2013, Prof. Geronikaki was elected as a Full member of Mediterranean Academy of Science and Arts and in 2015 Member of European Academy of Science and Arts. Her scientific interests include chemistry of natural products isolation, determination of structure; Chemistry of biologically active compounds and evaluation of their activity, using different computational methods. She has organized five International conferences. She had several grants, among which are INTAS, Pythagoras and others. She has received several awards from the International Scientific Foundation. She was an invited speaker in 46 International conferences. She is a member of the Editorial Board in several journals.
Bingjin Li The Second Hospital of Jilin University Changchun (China)
Dr. Bingjin Li is a graduate of Yanbian University, China. She received her Ph.D. from Ehime University, Japan. She performed postdoc training at Washington State University and is a full professor at the second hospital of Jilin University, China. Her lab uses behavioral and electrophysiological analyses to explore the underlying relationship between neuronal function and behavior. This integrative approach involves the use of molecular biology, biochemistry, immunocytohistochemistry, neurophysiology, anatomy, and a wide range of behavioral methodology to understand the function of the nervous system.
Hongmei Liu Department of Neurosurgery Xuzhou Medical University Xuzhou (China)
Dr. Hongmei Liu is as Associate Professor at Institute of Nervous System Diseases, Xuzhou Medical University, China. She worked as an Assistant Experimentalist at Experimental Center, Jilin Medical College. She obtained her Ph.D. from Institute of Process Engineering, Chinese Academy of Science, China. Dr. Liu’s research work mainly focus on designing a nanoparticle or a prodrug nanoparticle to deliver siRNA, anticancer drugs or radiosensitizers to improve radiochemotherapy for glioma treatment.
Xian-Hai Lv Department of Chemistry Anhui Agricultural University Hefei (China)
Dr. Xian-Hai Lv is currently working as an associate professor at Anhui Agricultural University, China. He received his MS degree in Pesticide Chemistry from Guizhou University and a Ph.D. degree in Agricultural Entomology and Pest Control from Anhui Agricultural University, China. His research interests are focused on the design and synthesis of novel molecules that possess unique biological activity, useful for biological and chemical biology research.
Nir Qvit The Azrieli Faculty of Medicine Bar-Ilan University Safed (Israel)
Dr. Qvit completed his doctorate in Organic Chemistry from the Hebrew University in 2008. He further joined the Department of Chemical and System Biology in Stanford School of Medicine as a postdoctoral fellow. His research focuses on the development of novel tools to regulate protein-protein interactions. He is serving as a reviewer for several scientific journals. He joined Bar-Ilan University’s team of researchers in the Galilee in October 2017, and currently, he is the head of the Laboratory for Chemical Biology of Protein-Protein Interactions at the School of Medicine.
Qinglin Shen Department of Oncology Nanchang University Nanchang (China)
Dr. Qinglin Shen is an Associate Professor at the Department of Oncology, the People’s Hospital of Jiangxi, Nanchang University, China. He worked as an Associate Professor at Cancer center, the Renmin Hospital of Wuhan University, China. Dr. Shen obtained his Ph.D. from Wuhan University. His area of research interest includes Detection of circulating tumor cells and its clinical application, Construction of tumor visualization model based on circulating tumor cells, Photothermal Therapy of Cancer.
Hande Sipahi Department of Toxicology Yeditepe University Istanbul (Turkey)
Assoc. Prof. Dr Hande Sipahi has graduated from Gazi University, Faculty of Pharmacy in 2002. She has completed her Master’s and PhD degree at Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology in 2006 and 2011, respectively. She started to work as a Full-time Assistant Professor at Yeditepe University in 2012 and got her Associate Professor degree in September 2015. She has participated in many scientific congresses and symposiums. She has over 35 articles published in international journals. Her main research areas are inflammation and oxidative stress markers, heavy metal toxicity, risk assessment, safety and biocompatibility tests for drugs and medical devices and in vitro alternative toxicity tests. She is a member of the Turkish Society of Toxicology and EUROTOX. She is also a European Registered Toxicologist (ERT) since 2017.
Drozdstoy Stoyanov Stoyanov Department of Psychiatry and Medical Psychology Faculty of Medicine Medical University of Plovdiv Plovdiv (Bulgaria)
Dr Drozdstoy Stoyanov holds currently the academic position of Full Professor and Head,
Neuropsychiatry and Brain Imaging Group, Medical University, Plovdiv.
He is Vice Chair of Philosophy SIG, Royal College of Psychiatrists, UK, Visiting Fellow in the
University of Pittsburgh, USA (2009), International Distinguished Fellow of the American
Psychiatric Association (2018), Guest Lecturer in the Universities of Copenhagen (2015), Vienna
(2017) and Bergen (2018).He published more than 160 scholarly papers, including five monographs and three textbooks.
Dr Stoyanov is Associate Editor of Frontiers in Psychiatry and the European Journal of Person
Centered Health Care; Editorial Board member of Dialogues in Philosophy, Mental and
Neurosciences, International Journal for Person Centered Medicine, Folia Medica and others.
Ad hoc reviewer in Current Medicinal Chemistry, Molecular Neurobiology, Human Brain Mapping,
Journal of Affective Disorders, Biotechnology and Biotechnological Equipement.
Suman S. Thakur Proteomics and Cell Signaling, Lab W110 Centre for Cellular and Molecular Biology Hyderabad (India)
Dr. S.S. Thakur research interests involve application of Mass Spectrometry based proteomics in Health and Disease especially biomarker discovery and Drug Development. His group uses mass spectrometry based high throughput quantitative proteomics, natural product chemistry, cell biology, animal model, stem cell, and modern biology approach to find the target, to develop novel drugs and elucidate its mode of action against cancer and other metabolic disorders such as diabetes. We are investigating the efficacy of various natural and synthetic metabolites on melanoma, retinoblastoma, leukemia, and lung cancer using in vitro and in vivo method including animal model. Further, investigating the molecular basis for Cell adhesion, AKT signaling and tyrosine kinase associated cancer progression and response and resistance to targeted therapy in these cancers is in progress in my lab.
Dharmendra Kumar Yadav College of Pharmacy Gachon University of Medicine and Science Incheon (South Korea)
Dharmendra Kumar Yadav was born in Deoria (U.P.), India. He has completed his PhD in, Biological Science from CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India and postdoctoral studies from Hanyang University Korea and University of Delhi, India. Presently, he is working as Assistant Professor and Principal Investigator of NRF project (Korea) in College of Pharmacy in Gachon University, Korea. He has recipient of 2014 Young Scientist award from the SERB, Science and Engineering Research Board, New Delhi. He had worked as Young Scientist at All India Institute of Medical Science Jodhpur, India. He has published more than 55 papers in reputed journals, 03 Book Chapter and US Patent. He is continuing his research in atomic level molecular simulation of Plasma Medicine, Computer-Aided Drug Design, Molecular Modelling and Molecular Dynamics Simulation of Biological networks etc. He is one of the Editorial members and reviewer of in many prestigious journals. He also has received several awards and honors in research career.
Yu Yu Department of Pediatric Cardiovascular, Xinhua Hospital, School of Medicine Shanghai Jiaotong University Shanghai (China)
Dr. Y. Yu started her career as an Associate Professor at the Chinese Academy of Sciences in 2014, then continued it at Xinhua Hospital, School of Medicine, Shanghai Jiaotong University since 2016. Her current research focuses on studying the molecular mechanism of cardiovascular disease or the genetic pathogenesis of congenital heart disease. She has published 59 articles in Chinese core journals and SCI Journals, such as J Clin Invest., Nat. Commun., Circ Res., EbioMedicine, J Bio Chem. and so on. Also, she had applied for 2 patents.
Bin Yu School of Pharmaceutical Sciences Zhengzhou University Zhengzhou (China)
Dr. Bin Yu obtained his B. Sc. and M. Sc. degrees from the School of Pharmaceutical Sciences, Zhengzhou University (ZZU), China in 2010 and 2012, respectively and then continued his doctoral work at the same university in 2012. As a visiting PhD student, he carried out his doctoral research work in the chemistry department, University of Cambridge (02/2014-02/2016), and obtained his PhD degree in July, 2016. His research interests mainly focus on chemistry driven drug discovery. Since 2016, he has been working at
the School of Pharmaceutical Sciences, ZZU and then promoted to a Professorship in 2020. He has contributed over 100 papers in international peer reviewed journals, two book chapters and 17 patents.
Guo-Ping Zhou Rocky Mount Life Sciences Institute Guangxi Academy of Sciences Nanning (China)
Dr. Guo-Ping Zhou is currently a Distinguished Professor of Gordon Life Science Institute, USA. He is also an Adjunct Professor of several academics in the United States and China. Dr. Zhou received his Ph.D. in Biophysics from the University of California at Davis, and completed his postdoctoral training at Stanford University and Harvard University, respectively. Dr. Zhou has successfully introduced the elegant wenxiang diagrams to elucidate the mechanisms of the coiled-coil proteins, protein- lipids, protein-DNA interactions, and prion protein misfolding observed by NMR. Meanwhile, he has also published many papers in Bioinformatics. His current research interests focus on the investigation into the intrinsic relationship between the functions and structures of polysialyltransferases, the suggested targets in metastatic cancer. In addition, As an Editorial Board Member or the invited Guest Editor, Dr. Zhou has also edited some special issues on structural biology for several influential scientific journals such as Current Topics in Medicinal Chemistry, Current Medicinal Chemistry, Medicinal Chemistry, Amino Acids, and as well as Protein & Peptide Letters.
Jia Zhou Chemical Biology Program Department of Pharmacology and Toxicology University of Texas Medical Branch Galveston, TX (USA) Biography
Biography of Jia Zhou
Dr. Jia Zhou is currently a tenured Professor in the Chemical Biology Program at University of Texas Medical Branch (UTMB), USA. He was educated with a PhD degree and trained as a postdoctoral research fellow from Nankai University, University of Virginia, and Georgetown University Medical Center, respectively. He has over 20 years of research experience in medicinal chemistry, drug discovery and development including 7 years of industrial experience in pharmaceuticals. Dr. Zhou’s research interest is drug discovery and development of novel small molecules as potential therapeutics for the treatment of central nervous system (CNS) disorders, cancer, inflammation, and infectious diseases. He is an author of more than 190 papers, 7 book chapters and an inventor of 26 patents. He is also a National Academy of Inventors (NAI) Fellow.
Current Topics in Medicinal Chemistry was introduced in 2001 with the assistance of Dr. Allen B. Reitz, who served as the editor-in-chief from 2001 to 2020. Currently, Dr. Jia Zhou is the Editor-in-Chief of the journal.